Foresite Capital Fund VI LP insider trades: Latigo Biotherapeutics (LTGO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Foresite Capital Fund VI LP reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | LTGO | ↑ Buy | 140,000 | $18.00 | $2.5M | Indirect | Aug 10, 2026 (0d) |
| Jan 8, 2026 | ALMS | ↑ Buy | 411,764 | $17.00 | $7.0M | Indirect | Jan 12, 2026 (4d) |
| Nov 21, 2025 | ALMS | ↑ Buy | 72,212 | $7.38 | $533K | Indirect | Nov 25, 2025 (4d) |
| Nov 19, 2025 | ALMS | ↑ Buy | 507,874 | $6.09 | $3.1M | Indirect | Nov 19, 2025 (0d) |
| May 6, 2025 | ALMS | ↑ Buy | 45,000 | $4.50 | $202K | Indirect | May 6, 2025 (0d) |
| Jul 1, 2024 | ALMS | ↑ Buy | 2,500,000 | $16.00 | $40.0M | Indirect | Jul 3, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LTGO insiders
Open-market trades in the last 12 months
About Foresite Capital Fund VI LP's insider trades
Foresite Capital Fund VI LP is a 10% owner of Latigo Biotherapeutics (LTGO). Since Jul 1, 2024, it has reported 6 open-market purchases worth $53.3M and no sales on SEC Form 4. In the last 12 months: 4 buys ($13.1M).
Its filings also include conversions (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LTGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.